Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Read More: Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know The growing demand for GLP-1 drugs, which mimic hormones that ...
Kingston: One of the most popular new year's resolutions is making a commitment to healthier eating. Whether that's eating ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback